9010:HK:HK- (USD)

ETF | Others |

Last Closing

USD 7.59

Change

-0.01 (-0.07)%

Market Cap

USD 3.03B

Volume

0.02M
Analyst Rating

Verdict

ducovest Verdict

Verdict

About

Unadjusted Closing Price

Adjusted Closing Price

Share Volume

Relative Performance (Total Returns)

Compare
Relative Returns (From:    To: 2025-05-28 )

Largest Industry Peers for Others

Symbol Name Price(Change) Market Cap
2800:HK Tracker Fund of Hong Kong

+0.24 (+1.00%)

USD 159.33B
2833:HK Hang Seng Index Tracking Fund

N/A

USD 30.97B
2828:HK Hang Seng China Enterprises In..

+1.04 (+1.18%)

USD 30.56B
2801:HK iShares Core MSCI China ETF

+0.22 (+0.92%)

USD 22.44B
2823:HK iShares FTSE A50 China

+0.11 (+0.79%)

USD 17.65B
83188:HK ChinaAMC CSI 300 Index ETF

+0.06 (+0.15%)

USD 13.48B
9067:HK iShares Hang Seng TECH ETF

-0.04 (-2.87%)

USD 9.22B
3067:HK iShares Hang Seng TECH ETF

+0.20 (+1.82%)

USD 9.22B
82822:HK CSOP FTSE China A50

+0.03 (+0.25%)

USD 8.59B
9846:HK iShares Core CSI 300

+0.02 (+0.56%)

USD 2.96B

ETFs Containing 9010:HK

RWDE 0.00 % 0.00 %

N/A

N/A

Market Performance

  Market Performance vs. Industry/Classification (Others) Market Performance vs. Exchange
  Value Sector Median Percentile Rank Grade Market Median Percentile Rank Grade
YTD  
Capital Gain 8.35% 68% D+ 65% D
Dividend Return N/A N/A N/A N/A N/A
Total Return 8.35% 68% D+ 64% D
Trailing 12 Months  
Capital Gain 10.48% 65% D 66% D+
Dividend Return 2.33% 33% F 20% F
Total Return 12.81% 67% D+ 66% D+
Trailing 5 Years  
Capital Gain 25.66% 72% C 74% C
Dividend Return 10.60% 53% F 28% F
Total Return 36.26% 72% C 72% C
Average Annual (5 Year Horizon)  
Capital Gain -1.38% 55% F 53% F
Dividend Return 0.21% 57% F 63% D
Total Return 1.59% 45% F 69% C-
Risk Return Profile  
Volatility (Standard Deviation) 16.17% 66% D+ 85% B
Risk Adjusted Return 1.31% 57% F 51% F
Market Capitalization 3.03B 70% C- 73% C

Annual Financials (USD)

Quarterly Financials (USD)

Analyst Rating

Target Price Action Rating Action Analyst Rating Price Date

This is a composite scorecard based on the application of evaluation criteria deemed most important by analysts. This is not a buy or sell recommendation.

What to like:

There is nothing we particularly like

What to not like:
Below median total returns

The company has under performed its peers on annual average total returns in the past 5 years.